Vertex Pharmaceuticals
VRTX
VRTX
522 hedge funds and large institutions have $25.8B invested in Vertex Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 86 funds opening new positions, 186 increasing their positions, 185 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1% more repeat investments, than reductions
Existing positions increased: 186 | Existing positions reduced: 185
0.29% less ownership
Funds ownership: 95.29% → 95% (-0.29%)
1% less call options, than puts
Call options by funds: $257M | Put options by funds: $259M
Holders
522
Holding in Top 10
8
Calls
$257M
Puts
$259M
Top Buyers
| 1 | +$2.03B | |
| 2 | +$311M | |
| 3 | +$122M | |
| 4 |
HM
HealthCor Management
New York
|
+$112M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$109M |
Top Sellers
| 1 | -$312M | |
| 2 | -$135M | |
| 3 | -$135M | |
| 4 |
UBS AM
Chicago,
Illinois
|
-$95.1M |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$90.3M |